Study
T-cell based immunotherapies show remarkable potential for treating cancer, autoimmunity, and infectious disease. Although studying T-cell biology and developing potential therapeutics relies on gene delivery, effective, scalable T-cell modification remains a technical challenge.
Traditional gene delivery methods like viral vectors and electroporation come with risks for mutagenesis, immunogenicity, cell damage, or poor efficiency. Non-viral mRNA transfection offers a safe, less expensive, and more efficient alternative for T-cells and other difficult-to-transfect cell types.
Download this study from Sartorius for a detailed example of how to optimize mRNA transfection in human T-cells and receive a complimentary mRNA transfection reagent sample.
Offered Free by: Sartorius
See All Resources from: Sartorius
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.





